Xuanwu Hospital, Beijing: Parkinson Disease trials
The registry lists 15 Parkinson Disease studies with Xuanwu Hospital, Beijing as lead sponsor. 8 are open to participants now and 1 have results posted.
Phase 1 2Phase 2 3Phase 3 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Cognition and Affective Research in ChinaNot yet recruitingNCT07833267
- Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PDRecruitingNCT06914466
- Constant Current Versus Constant Voltage Subthalamic Nucleus Deep Brain Stimulation in Patients with Parkinson's DiseaseRecruitingNCT06742450Not applicable
- hUC-MSC-sEV-001 Nasal Drops for Neurodegenerative DiseasesNot yet recruitingNCT06607900Phase 1
- AV133 Longitudinal Imaging Study in Patients With Early and Prdromal Parkinson's DiseaseRecruitingNCT06456684
- Vibrotactile Foot Device for Freezing of Gait in Parkinson's DiseaseRecruitingNCT06147713Not applicable
- Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/DiseaseRecruitingNCT06092125
- Safety and Efficacy of Autologous iNSC-DAP in the Treatment of Parkinson's DiseaseRecruitingNCT05901818Phase 1
- rTMS for the Treatment of Freezing of Gait in Parkinson's DiseaseCompletedNCT03219892Not applicableResults posted
- LRRK2 Activity and Markers of Parkinson's Disease in G2385R CarriersCompletedNCT04349865
- TMS Treatment in Parkinson's Disease With Pain.CompletedNCT04048265Not applicable
- Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's DiseaseStatus unknownNCT03594656Phase 3
- Treatment of Depression in Parkinson's DiseaseStatus unknownNCT01416818Phase 2
- Efficacy and Safety of Green Tea Polyphenol in De Novo Parkinson's Disease PatientsCompletedNCT00461942Phase 2
- Efficacy and Safety of Lingzhi in Patients With Early Parkinson's DiseaseCompletedNCT00224263Phase 2